➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Dow
McKinsey
Colorcon
Merck

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,962,151


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,962,151
Title: Inhalation nebulizer
Abstract:An inhalation nebulizer (1) includes an aerosol generator (2) that has a diaphragm (22) vibrated by a vibration generator (23). The inhalation nebulizer (1) includes a liquid storage container (21) that is in fluid contact with the diaphragm (22). A liquid contained in the storage container (21) is atomized into a mixing chamber (3) through openings in the diaphragm and can subsequently be inhaled by a patient.
Inventor(s): Knoch; Martin (Berg, DE), Keller; Manfred (Bad Krozingen, DE), Stangl; Roland (Moosburg, DE), Gallem; Thomas (Munich, DE), Liening-Ewert; Rainer (Alfausen, DE), Urich; Markus (Munich, DE)
Assignee: Pari GmbH Spezialisten fur effektive Inhalation (Starnberg, DE)
Application Number:10/129,498
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device; Dosage form;

Drugs Protected by US Patent 6,962,151

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,962,151

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 53 317Nov 5, 1999
PCT Information
PCT FiledOctober 27, 2000PCT Application Number:PCT/US00/29541
PCT Publication Date:May 17, 2001PCT Publication Number: WO01/34232

International Family Members for US Patent 6,962,151

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 404234 ⤷  Try it Free
Australia 1234801 ⤷  Try it Free
Australia 1698301 ⤷  Try it Free
Australia 781911 ⤷  Try it Free
Canada 2389936 ⤷  Try it Free
Germany 19953317 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Medtronic
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.